Stocks in play: Héroux-Devtek Inc.
Announced that the Toronto Stock Exchange has approved the renewal of its normal course issuer bid. Under the NCIB, Héroux-Devtek has the right to purchase for cancellation, from May 25, 2022 to May 24, 2023, a maximum of 1,896,079 common shares, representing, as of May 11, 2022, 10% of the public float of 18,960,792 common shares. The Corporation had 34,486,776 common shares issued and outstanding as of May 11. Héroux-Devtek Inc. shares T.HRX are trading unchanged at $14.25.
Read:
Innovative Food Stocks Responding to Conflict-, and Drought-Driven Food Supply Shocks
Crypto Miners Finding Success While Shifting Towards Environmentally Sustainable Operations
New Approaches Towards Immunotherapy Give Hope in Fight Against Solid Tumors
As a Major Social Media Shuffle Looms, Uptake and Value of Dogecoin (DOGE) Surges
New Regions Being Developed to Produce More Oil Amid Government’s Calls for More Output